Open AccessMenorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
Author(s) -
Jalil Feizi,
Ali Nazari,
Abbas Ghaysouri,
Mahtab Bonyadi,
Elham Shafiei
Publication year - 2020
Publication title -
international journal of medical toxicology and forensic medicine
Language(s) - English
Resource type - Journals
eISSN - 2251-8770
pISSN - 2251-8762
DOI - 10.32598/ijmtfm.v10i3.29640
Subject(s) - rivaroxaban , medicine , adverse effect , oral anticoagulant , presentation (obstetrics) , thrombosis , anticoagulant , major bleeding , intensive care medicine , surgery , anesthesia , warfarin , atrial fibrillation
Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects. One of the most significant, but rare side effects of them in women is severe and dangerous bleeding.
Case presentation: In this study, we reported a case of severe vaginal bleeding (manometric hemorrhage) in a woman receiving rivaroxaban to prevent pulmonary thrombosis.
Conclusion: The oral anticoagulant rivaroxaban could present a rare adverse effect on women.